We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Performance of Hematology Analyzer and Peripherals Evaluated

By LabMedica International staff writers
Posted on 05 Oct 2016
Print article
Image: The CAL 8000 hematology automation line consisting of the BC-6800 and SC-120 (Photo courtesy of Mindray).
Image: The CAL 8000 hematology automation line consisting of the BC-6800 and SC-120 (Photo courtesy of Mindray).
The complete blood count and leukocyte differential count are the basic, most common tests in hematology laboratories. More tests can be performed at the same time; labor reduced, and results made more precise by an advanced automated hematology analyzer and slidemaker/stainer.

Reducing review of unnecessary blood film without missing true abnormal samples is the goal of automated hematology analyzers, because manual review increases laboratory cost, labor, and turnaround time. For the same reason, automated slidemaker/strainers demand quick, high-quality blood films.

Hematologists at the Gachon University Gil Medical Center (Incheon, Korea) selected 408 samples to evaluate a new hematology analyzer. Samples were collected from patients who needed a peripheral blood smear test by physicians' recommendation and from patients who had regular checkups. Two hundred of 408 samples showed flags, and 208 samples did not show any flags by the regular analyzer used in the laboratory.

The scientists compared the CAL 8000 (Mindray Bio-Medical Electronics Co, Ltd, Shenzhen, China) which is a cellular analysis line consisting of the Mindray BC-6800, an automated hematology analyzer, and the Mindray SC-120, an automated slidemaker/stainer and compared the analyzer results with the data from the XE-2100 automated hematology analyzer (Sysmex, Kobe, Japan) and the slidemaker with a manual method.

The team reported that most parameters measured by the BC-6800 matched well with the XE-2100 and manual differential. The flag efficiency of the BC-6800 for blasts (95.3%) and atypical lymphocytes (92.6%) were higher while immature granulocytes (89.7%) and nucleated red blood cells (94.1%) were lower than that of the XE-2100. Additionally, the BC-6800 detected four of five samples infected with malaria parasites. The SC-120 showed no carry-over and expected repeatability. There was good agreement on the five-part differential including abnormal cells between blood films by the SC-120 and manually prepared blood films. The shape of the red blood cells (RBC) was also comparable between blood films.

The authors concluded that the performance of BC-6800 was comparable with the XE-2100, and has a further advantage of detecting infection of malaria parasite. The SC-120 agreed well with manual differential and morphology assessment although the SC-120 needed the adjustment for stain precipitate and steaks. Therefore, the CAL-8000 is effective for precise, fast hematology work, and has useful application for malaria endemic areas. The study was published on September 23, 2016, in the Journal of Clinical Laboratory Analysis.

Related Links:
Gachon University Gil Medical Center
Mindray Bio-Medical Electronics
Sysmex
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Piezoelectric Micropump
Disc Pump
New
Thrombin Test
i-STAT ACTc Cartridge

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.